Umbralisib and ublituximab in patients with CLL and comorbidities VJHemOnc – Video Journal of Hematology & HemOnc 1:55 2 years ago 104 Далее Скачать
Umbralisib plus ublituximab vs. standard of care chemoimmunotherapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:39 3 years ago 158 Далее Скачать
Umbralisib + ublituximab shows superior outcomes to standard of care chemoimmunotherapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 4:00 4 years ago 203 Далее Скачать
Dr. Barr on Umbralisib/Ublituximab/Venetoclax in Relapsed/Refractory CLL OncLive 1:39 4 years ago 650 Далее Скачать
Ublituximab, umbralisib and ibrutinib in CLL and NHL VJHemOnc – Video Journal of Hematology & HemOnc 2:01 5 years ago 449 Далее Скачать
Umbralisib, ublituximab and venetoclax in patients with relapsed or refractory chronic lymphocyt... ecancer 4:54 5 years ago 262 Далее Скачать
Acalabrutinib, umbralisib & ublituximab (AU2) regimen in patients with de novo MCL VJHemOnc – Video Journal of Hematology & HemOnc 2:02 5 days ago No Далее Скачать
Triple therapy for CLL: pembrolizumab, ublituximab and umbralisib VJHemOnc – Video Journal of Hematology & HemOnc 3:21 6 years ago 212 Далее Скачать
Advancements within the CLL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 2:18 3 years ago 159 Далее Скачать
TG-1701: monotherapy & combination with U2 for CLL and lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 3:33 3 years ago 60 Далее Скачать
U2' regimen with checkpoint inhibition in R/R CLL and Richter's transformation VJHemOnc – Video Journal of Hematology & HemOnc 1:37 5 years ago 69 Далее Скачать
Comment on fixed-duration venetoclax plus obinutuzumab in patients with CLL and comorbidities ecancer 1:26 5 years ago 61 Далее Скачать
Umbralisib for CLL patients intolerant to BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:55 3 years ago 173 Далее Скачать
Ibrutinib Plus Umbralisib Induce Survival Benefit in Patients With CLL Targeted Oncology 0:45 4 years ago 105 Далее Скачать
Key clinical trials in CLL at ASH 2020 VJHemOnc – Video Journal of Hematology & HemOnc 1:49 3 years ago 72 Далее Скачать
Ibrutinib and ublituximab – a promising combination regimen for treating CLL? VJHemOnc – Video Journal of Hematology & HemOnc 5:35 7 years ago 948 Далее Скачать
Impact of comorbidities & patient preference in treatment selection for elderly patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 1 year ago 59 Далее Скачать
Obinutuzumab increases survival in CLL patients with comorbidities VJHemOnc – Video Journal of Hematology & HemOnc 2:04 6 years ago 257 Далее Скачать
The impact of comorbidity burden on treatment decisions in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 193 Далее Скачать
TG-1701, a novel BTKi, in B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 2:21 3 years ago 68 Далее Скачать
